Biotech · Private company · Woodinville, WA, US
Cancer Targeted Technology
Track this companyFree. Adds Cancer Targeted Technology to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 68Ga-PSMA-11Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- CTT1057Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- CTT1057Phase 1 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CTT1403Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Trial of CTT1403 for Metastatic Castration Resistant Prostate CancerPHASE1 · COMPLETED · started Apr 1, 2019ClinicalTrials.gov NCT03822871 · fetched Nov 12, 2026
- CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell CarcinomaPHASE1 · COMPLETED · started Jan 1, 2018ClinicalTrials.gov NCT03427476 · fetched Nov 12, 2026
NIH awards2
- Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate CancerFiscal year 2025 · $2MNIH RePORTER 4R44CA290973-02 · fetched Nov 12, 2026
- Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate CancerFiscal year 2024 · $400KNIH RePORTER 1R44CA290973-01 · fetched Nov 12, 2026